Catalyst Pharmaceuticals Inc (CPRX)
Financial leverage ratio
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total assets | US$ in thousands | 851,411 | 772,010 | 706,360 | 646,676 | 471,907 | 413,211 | 443,896 | 407,227 | 375,630 | 333,114 | 267,309 | 246,972 | 237,788 | 223,248 | 209,130 | 197,216 | 192,354 | 174,860 | 131,412 | 117,880 |
Total stockholders’ equity | US$ in thousands | 727,632 | 660,941 | 608,655 | 561,412 | 387,881 | 348,548 | 375,294 | 333,661 | 300,421 | 270,041 | 241,092 | 220,221 | 206,831 | 198,661 | 188,944 | 178,651 | 169,598 | 156,628 | 111,201 | 99,676 |
Financial leverage ratio | 1.17 | 1.17 | 1.16 | 1.15 | 1.22 | 1.19 | 1.18 | 1.22 | 1.25 | 1.23 | 1.11 | 1.12 | 1.15 | 1.12 | 1.11 | 1.10 | 1.13 | 1.12 | 1.18 | 1.18 |
December 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $851,411K ÷ $727,632K
= 1.17
The financial leverage ratio of Catalyst Pharmaceuticals Inc has shown slight fluctuations over the period analyzed. The ratio ranged from 1.10 to 1.25 during the period from March 31, 2021, to December 31, 2024. The ratio indicates that the company's debt level relative to its equity has been relatively stable, with a moderate trend towards higher leverage in the more recent quarters. A financial leverage ratio above 1 indicates that the company relies more on debt financing than equity financing. It is important to note that while moderate leverage can amplify returns, it also increases financial risk and debt servicing obligations for the company. Further analysis of the company's debt structure and overall financial health would provide a more comprehensive understanding of Catalyst Pharmaceuticals Inc's leverage position.
Peer comparison
Dec 31, 2024